Daiwa-Securities-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa-Securities-Group
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions • $15.0M total value
Manager:
Search and click to pin securities to the top
Page 59 of 64
Spyre Therapeutics, Inc.
Shares:206
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
AbCellera Biologics Inc.
Shares:1.2K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Zymeworks Inc.
Shares:286
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Grifols SA
Shares:398
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
GRAIL, Inc.
Shares:98
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Bitdeer Technologies Group
Shares:250
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
10x Genomics, Inc.
Shares:370
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
AVADEL PHARMACEUTICALS PLC
Shares:332
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Kiniksa Pharmaceuticals International, plc
Shares:139
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
HARROW, INC.
Shares:110
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Nurix Therapeutics, Inc.
Shares:245
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
ANAVEX LIFE SCIENCES CORP.
Shares:314
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
Vir Biotechnology, Inc.
Shares:535
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$15.0M)
UroGen Pharma Ltd.
Shares:160
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Alpha Teknova, Inc.
Shares:300
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Praxis Precision Medicines, Inc.
Shares:62
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
CASTLE BIOSCIENCES INC
Shares:86
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
ANAPTYSBIO, INC
Shares:105
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
Replimune Group, Inc.
Shares:200
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)
KalVista Pharmaceuticals, Inc.
Shares:154
Value:$2.0K
% of Portfolio:0.0% ($2.0K/$15.0M)